QOF Disease Prevalence Coding Support
Our Clinical Pharmacists are now able to offer coding support across a number of QOF domains
Empowering Practices to Deliver NHS CVD Priorities
We help primary care teams deliver cardiovascular outcomes by combining intelligent platforms with expert mentoring, turning data into action, closing care gaps and aligning with NHS priorities.
>70%
PCNs worked with us in the last 12 months
3,600
Practices in the last 5 years
>35M
patients supported
NHS aligned workflows ✨
How it works
1
Identify gaps
Surface uncoded or under-coded patients missing from clinical registers, and assess indicator achievement.
2
Create Workflows with Expert Mentorship
Build targeted workflows to improve registers and indicators achievement, guided by our experienced clinical team.
3
Deliver results
Enhance delivery, improve prevalence and track progress against key indicators.
IMPACT CVD Prevalence
- Focused searches across AF, HF, CHD, PAD, Stroke/TIA and Hypertension, using QOF-recognised codes to ensure validated changes that accurately uplift clinical registers.
Coding Session
Optional revalidation
Attend2 CVD Indicators
- Using our Attend2 platform, we help practices identify priority cohorts and create practical workflows turning clinical data into actionable plans that improve care delivery.
Mentoring Day
One data refresh
Support & Mentoring
Our difference: we don’t leave you with tools. We sit alongside your team to configure, prioritise and activate work, so cohorts move to action immediately. Mentoring focuses on BP & lipids, skill-mix workflows and inequalities with clear ownership and next steps.
Mentoring Day
Co-design Attend2 segments, workflows and comms. Upskill staff, agree owners, and line up the next day’s stretegy.
Coding Session
Proactively code and validate for register uplift across AF, HF, CHD, PAD, Stroke/TIA, Hypertension.
Outcomes that matter
Clean, accurate registers; prioritised cohorts; governance-aligned action plans.
?
Which tool do I need?
| Capability | IMPACT CVD Prevalence | Attend2 CVD Indicators |
|---|---|---|
| Primary outcome | Recorded prevalence uplift (register optimisation) | Indicator attainment and delivery |
| Typical users | Practice teams | Practice teams, PCN leads |
| Data focus | Missing/uncoded or under-coded patients | Incomplete indicators, recalls, and follow-ups |
| Outputs | Patients on CVD registers | Clear strategy on how to implement indicators |
| Best for | Prevalence uplift & funding accuracy | Sustained indicator performance across sites |
Testimonials
What practices, PCNs and ICBs say about working with us.
“AS ALWAYS WE FOUND INTERFACE CLINICAL SERVICE EXCELLENT – delivered a seamless lipid pathway, helping us close gaps in our CVD prevention QOF and reach 95% coding.”
— Oxted Health Centre, NHS – Lipid Management Health Inequalities
“79 of our patients were reviewed in six clinics, leading to a 40% increase in our lipid QOF income and clearer risk stratification for high-risk CVD patients.”
— Penketh Health Centre, Lipid Management
“This atrial fibrillation screening exercise is incredibly valuable, as it has the potential to identify patients with undiagnosed AF and prevent decline in quality of life.”
— Camp Hill GP-Led Health Centre
Daiichi Sankyo – AF Screening
Frequently asked questions
How quickly can I see impact?
Most practices see measurable improvements within 4–6 weeks for prevalence uplift. Indicator delivery is ongoing but dashboards show progress immediately.
Is support available for implementation?
Yes, clinician support is provided to guide you through patient lists, coding changes, and dashboard use.
Can both tools be used together?
Absolutely. Prevalence helps surface missing patients, and Attend2 tracks and delivers the indicators. Together, they ensure comprehensive coverage.